Report: Advil and Sensodyne maker Haleon to cut ‘potentially thousands’ of jobs

Roughly a year after being spun off from pharmaceutical giant GlaxoSmithKline (GSK), Haleon is reportedly planning deep job cuts.

According to The Guardian, the company behind major brands, including Advil and Sensodyne toothpaste, intends to eliminate hundreds of roles in the U.K. and potentially thousands worldwide.

“We’ve announced internally a number of changes to our global business this week, as we continue to evolve Haleon into a more agile organization,” a spokesperson said in a statement.

“As we shared in March, this is part of a broader three-year program that will help drive increased productivity across the business, ensuring that Haleon continues to deliver for consumers over the long term.”

The consumer healthcare business began a consultation process on July 12. It’s expected to finish on Aug. 25.

The Guardian claims that laid-off staff are expected to leave the company in September.

Haleon employs a global workforce of more than 24,000 people, according to multiple news outlets.

Impact on Canadian staff

It remains unclear if Canadian employees will be affected by job cuts at Haleon.

According to LinkedIn, the company has more than 370 workers in the country.

📺 WATCH: Everything You Need to Know About Mass Terminations

Lost Your Job? Get Help Now

📞 Contact Samfiru Tumarkin LLP: 1-855-821-5900 or request a consultation online.

Our experienced employment lawyers in Ontario, Alberta, and British Columbia (BC) have helped tens of thousands of non-unionized individuals resolve their workplace issues, including wrongful dismissals.

If you’ve lost your job at Haleon for any reason, don’t panic. We can review your situation, assess your legal options, and help you secure the compensation you’re legally entitled to.